Biodegradable Hollow Nanoscavengers Restore Liver Functions to Reverse Insulin Resistance in Type 2 Diabetes
ACS Nano · 2023
DOI: 10.1021/acsnano.3c00875 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, 2023. Verfasst von Zhibin Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry …. Hauptthemen laut MEDLINE: Insulin Resistance, Diabetes Mellitus, Type 2, Diabetes Mellitus, Experimental, Metal Nanoparticles. Die Arbeit wurde bisher 51-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Jiangsu Science and Technology Department, National Natural Science Foundation of China.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Type 2 diabetes (T2D) results from the cells' insulin resistance, and to date, insulin therapy and diabetes medications targeting glycemic management have failed to reverse the increase in T2D prevalence. Restoring liver functions to improve hepatic insulin resistance by reducing oxidative stress is a potential strategy for T2D treatment. Herein, the liver-targeted biodegradable silica nanoshells embedded with platinum nanoparticles (Pt-SiO2) are designed as reactive oxygen species (ROS) nanoscavengers and functional hollow nanocarriers. Then, 2,4-dinitrophenol-methyl ether (DNPME, mitochondrial uncoupler) is loaded inside Pt-SiO2, followed by coating a lipid bilayer (D@Pt-SiO2@L) for long-term effective ROS removal (platinum nanoparticles scavenge overproduced ROS, while DNPME inhibits ROS production) in the liver tissue of T2D models. It is found that D@Pt-SiO2@L reverses elevated oxidative stress, insulin resistance, and impaired glucose consumption in vitro, and significantly improves hepatic steatosis and antioxidant capacity in diabetic mice models induced by a high-fat diet and streptozotocin. Moreover, intravenous administration of D@Pt-SiO2@L indicates therapeutic effects on hyperlipidemia, insulin resistance, hyperglycemia, and diabetic nephropathy, which provides a promising approach for T2D treatment by reversing hepatic insulin resistance through long-term ROS scavenging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Engineering and Applied Sciences, Jiangsu Key Laboratory of Artificial Functional Materials, State Key Laboratory of Analytical Chemistry for Life Science, Collaborative Innovation Center of Advanced Microstr…
- Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210093, China.
- Department of Biochemistry and Molecular Biology, School of Medicine & Holistic Integrative Medicine, Jiangsu Collaborative Innovation Center of Chinese Medicinal Resources Industrialization, Nanjing University of Chine…
ORCID-Profile: Shaochun Tang, Yujun Song
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Jiangsu Science and Technology Department
- National Natural Science Foundation of China
- Program for Innovative Talents and Entrepreneur in Jiangsu
Zitieren
APA
Zhang, Z., Zhou, D., Luan, X., Wang, X., Zhu, Z., Luo, W., Yang, J., Tang, S., & Song, Y. (2023). Biodegradable Hollow Nanoscavengers Restore Liver Functions to Reverse Insulin Resistance in Type 2 Diabetes. ACS Nano. https://doi.org/10.1021/acsnano.3c00875
Vancouver
Zhang Z, Zhou D, Luan X, Wang X, Zhu Z, Luo W, et al. Biodegradable Hollow Nanoscavengers Restore Liver Functions to Reverse Insulin Resistance in Type 2 Diabetes. ACS Nano. 2023. doi:10.1021/acsnano.3c00875
BibTeX
@article{Zhang2023,
author = {Zhang, Zhibin and Zhou, Dongtao and Luan, Xiaowei and Wang, Xuyuan and Zhu, Zhenxing and Luo, Wen and Yang, Jingjing and Tang, Shaochun and Song, Yujun},
title = {Biodegradable Hollow Nanoscavengers Restore Liver Functions to Reverse Insulin Resistance in Type 2 Diabetes},
journal = {ACS Nano},
year = {2023},
doi = {10.1021/acsnano.3c00875}
}
EUVIMED